Yuta Myojin

7PUBLICATIONS
20CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 02, 2026
Immune checkpoint inhibitor-associated hepatitis and colitis: current understanding and clinical approaches.

|Mar 30, 2026
Systemic immune profiling uncovers divergent mechanisms and predictive biomarkers of response to combination immunotherapies in hepatocellular carcinoma.

Akira Nishio, Takahiro Kodama, Kazuma Daiku

|Jan 09, 2026
Response to Letter: Enhancing Robustness in Prognostic Biomarker Research: A Letter on Validating Model Assumptions and Handling Zero Events.

Yuta Myojin, Hayato Hikita

|Dec 23, 2025
Growth differentiation factor 15: from stress response to clinical utility in chronic liver diseases.

Yuta Myojin, Hayato Hikita

|Feb 18, 2025
Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab.

Yuta Myojin, Sepideh Babaei, Rajiv Trehan

|Jun 03, 2024
Proteomic analysis of serum extracellular vesicles reveals Fibulin-3 as a new marker predicting liver-related events in MASLD.

Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai

Pageof 2

Frequent Collaborators

2 joint publications

Hayato Hikita

2 joint publications

Takahiro Kodama

2 joint publications

Tim F Greten

2 joint publications

Firouzeh Korangy